What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NAS:AGIO Key Ratios
| Market Cap $ M | 1,687.37 |
| Enterprise Value $ M | 839.76 |
| P/E(ttm) | 2.60 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.09 |
| Price/Sales | 46.48 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 2.99 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 36.00 |
| EPS (TTM) $ | 11.34 |
| Beneish M-Score | 1.94 |
| 10-y EBITDA Growth Rate % | -11.00 |
| 5-y EBITDA Growth Rate % | -8.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.97 |
| EV-to-EBITDA | -2.00 |
| PEG | -- |
| Shares Outstanding M | 57.30 |
| Net Margin (%) | 1,845.92 |
| Operating Margin % | -1,166.47 |
| Pre-tax Margin (%) | 1,967.15 |
| Quick Ratio | 11.56 |
| Current Ratio | 11.90 |
| ROA % (ttm) | 56.00 |
| ROE % (ttm) | 62.58 |
| ROIC % (ttm) | -98.54 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.31 |
AGIO Number of Guru Trades
AGIO Volume of Guru Trades
Gurus Latest Trades with NAS:AGIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AGIO is held by these investors
Total 2
Agios Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AGIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers